PT - JOURNAL ARTICLE AU - Parry, Nicola ED - DeFronzo, Ralph A. TI - Combining Empagliflozin and Linagliptin with Metformin Reduces HbA1c in Patients with T2DM DP - 2014 Dec 01 TA - MD Conference Express PG - 11--12 VI - 14 IP - 32 4099 - http://mdc.sagepub.com/content/14/32/11.short 4100 - http://mdc.sagepub.com/content/14/32/11.full AB - Combined empagliflozin and linagliptin as add-on therapy to metformin provided enhanced glucose-reducing efficacy when compared with either drug as monotherapy in individuals with type 2 diabetes mellitus, as discussed in this article.